“Pharmaceutical executives who recently made a major donation to an anti-marijuana legalization campaign claimed they were doing so out of concern for the safety of children — but their investor filings reveal that pot poses a direct threat to their plans to cash in on a synthetic cannabis product they have developed.”
Related Posts
One striking chart shows why pharma companies are fighting legal marijuana
- WOCredentials
- August 15, 2016
- 0
“Our findings and existing clinical literature imply that patients respond to medical marijuana legislation as if there are clinical benefits to the drug, which adds to the growing body of […]
Cannabidiol Treatment in Osteoarthritic Dogs
- WOCredentials
- June 5, 2019
- 0
“This pharmacokinetic and clinical study suggests that 2 mg/kg of CBD twice daily can help increase comfort and activity in dogs with OA.”
Cannabis-based medicine may cut seizures in half
- WOCredentials
- April 19, 2017
- 0
“Taking cannabidiol may cut seizures in half for some children and adults with Lennox-Gastaut syndrome (LGS), a severe form of epilepsy”